| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 9909 | 2021 |
| Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis CS Graham, LR Baden, E Yu, JM Mrus, J Carnie, T Heeren, MJ Koziel Clinical infectious diseases 33 (4), 562-569, 2001 | 1309 | 2001 |
| Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19) A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VCC Cheng, ... Clinical Infectious Diseases, ciaa478, 2020 | 1278 | 2020 |
| Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia TJ Walsh, H Teppler, GR Donowitz, JA Maertens, LR Baden, ... New England Journal of Medicine 351 (14), 1391-1402, 2004 | 1177 | 2004 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1131 | 2020 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 902 | 2022 |
| SARS-CoV-2 viral load is associated with increased disease severity and mortality J Fajnzylber, J Regan, K Coxen, H Corry, C Wong, A Rosenthal, D Worrall, ... Nature communications 11 (1), 5493, 2020 | 845 | 2020 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 512 | 2021 |
| A bivalent omicron-containing booster vaccine against Covid-19 S Chalkias, C Harper, K Vrbicky, SR Walsh, B Essink, A Brosz, N McGhee, ... New England Journal of Medicine 387 (14), 1279-1291, 2022 | 504 | 2022 |
| Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation JR Wingard, SL Carter, TJ Walsh, J Kurtzberg, TN Small, LR Baden, ... Blood, The Journal of the American Society of Hematology 116 (24), 5111-5118, 2010 | 496 | 2010 |
| Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants FM Marty, LA Cosimi, LR Baden New England Journal of Medicine 350 (9), 950-952, 2004 | 487 | 2004 |
| American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2 JR Curtis, SR Johnson, DD Anthony, RJ Arasaratnam, LR Baden, ... Arthritis & Rheumatology 73 (8), e30-e45, 2021 | 480 | 2021 |
| Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of … BH Segal, R Herbrecht, DA Stevens, L Ostrosky-Zeichner, J Sobel, ... Clinical infectious diseases 47 (5), 674-683, 2008 | 478 | 2008 |
| American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 2 TR Mikuls, SR Johnson, L Fraenkel, RJ Arasaratnam, LR Baden, ... Arthritis & rheumatology 72 (9), e1-e12, 2020 | 425 | 2020 |
| Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines Z Zhai, C Li, Y Chen, G Gerotziafas, Z Zhang, J Wan, P Liu, I Elalamy, ... Thrombosis and haemostasis 120 (06), 937-948, 2020 | 422 | 2020 |
| Covid-19—the search for effective therapy LR Baden, EJ Rubin New England Journal of Medicine 382 (19), 1851-1852, 2020 | 403 | 2020 |
| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 358 | 2022 |
| Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology AW Chung, MP Kumar, KB Arnold, WH Yu, MK Schoen, LJ Dunphy, ... Cell 163 (4), 988-998, 2015 | 355 | 2015 |
| Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology LR Baden, S Swaminathan, M Angarone, G Blouin, BC Camins, C Casper, ... Journal of the National Comprehensive Cancer Network 14 (7), 882-913, 2016 | 353 | 2016 |
| Enterovirus 71 infections and neurologic disease—United States, 1977–1991 JP Alexander Jr, L Baden, MA Pallansch, LJ Anderson Journal of Infectious Diseases 169 (4), 905-908, 1994 | 337 | 1994 |
